Reports for SANDOZ CANADA INCORPORATED

Company Name

SANDOZ CANADA INCORPORATED

Totals

Shortage reports

1819

Actual shortage: 53 (3%)
Anticipated shortage: 9 (0%)
Avoided shortage: 13 (1%)
Resolved: 1744 (96%)

Discontinuation Reports

74

To be discontinued: 1 (1%)
Discontinued: 71 (96%)
Reversed: 2 (3%)

Late reports

439 (23%)

Overdue reports

1 (2%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
SANDOZ IRBESARTAN HCT 12.5MG 150MG TABLET Resolved 2019-01-21 2020-07-20 73141
SANDOZ IRBESARTAN HCT 12.5MG 150MG TABLET Resolved 2019-01-21 2020-07-20 73144
SANDOZ IRBESARTAN HCT 12.5MG 300MG TABLET Resolved 2019-03-05 2020-07-20 77655
SANDOZ IRBESARTAN HCT 12.5MG 300MG TABLET Resolved 2019-04-01 2020-06-22 80194
SANDOZ IRBESARTAN HCT 25MG 300MG TABLET Resolved 2019-04-01 2020-07-20 80197
SANDOZ IRBESARTAN HCT 25MG 300MG TABLET Resolved 2019-04-01 2020-07-20 80200
SANDOZ IRBESARTAN HCT 150MG 12.5MG TABLET Resolved 2020-09-21 2020-10-27 124600
SANDOZ IRBESARTAN HCT 150MG 12.5MG TABLET Resolved 2020-09-21 2020-10-27 124606
SANDOZ IRBESARTAN HCT 300MG 12.5MG TABLET Resolved 2020-09-21 2020-10-27 124609
SANDOZ IRBESARTAN HCT 300MG 12.5MG TABLET Resolved 2020-09-21 2020-10-27 124612
SANDOZ IRBESARTAN HCT 300MG 25MG TABLET Resolved 2020-09-21 2020-10-27 124617
SANDOZ IRBESARTAN HCT 300MG 25MG TABLET Resolved 2020-09-21 2020-10-27 124621
SANDOZ IRBESARTAN HCT 150MG 12.5MG TABLET Resolved 2020-11-27 2020-12-09 129102
SANDOZ IRBESARTAN HCT 150MG 12.5MG TABLET Resolved 2021-01-12 2021-03-08 131394
SANDOZ IRBESARTAN HCT 25MG 300MG TABLET Resolved 2021-10-19 2021-10-26 147570
SANDOZ IRBESARTAN HCT 25MG 300MG TABLET Resolved 2023-02-14 2023-03-28 184632
SANDOZ IRBESARTAN HCT 12.5MG 300MG TABLET Resolved 2023-03-06 2023-03-28 186285
SANDOZ IRBESARTAN HCT 12.5MG 150MG TABLET Resolved 2023-03-13 2023-04-18 186967
SANDOZ IRBESARTAN HCT 12.5MG 150MG TABLET Resolved 2023-03-13 2023-05-03 186971
SANDOZ IRBESARTAN HCT 25MG 300MG TABLET Resolved 2023-07-31 2024-01-09 200534

Showing 981 to 1000 of 1819

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ALFENTANIL INJECTION USP Discontinued 2019-10-15 2019-10-15 96610
ATRACURIUM BESYLATE INJECTION Discontinued 2019-10-15 2019-10-15 96613
BETAJECT Discontinued 2019-10-15 2019-10-15 96616
BLUE COLLYRIUM Discontinued 2019-10-15 2019-10-15 96619
BRETYLIUM TOSYLATE INJECTION USP 50MG SOLUTION Discontinued 2017-12-06 2017-12-06 31958
BRETYLIUM TOSYLATE INJECTION USP Discontinued 2020-04-01 2020-04-01 110288
CLINDAMYCIN INJECTION USP 150MG LIQUID Discontinued 2017-06-06 2017-10-18 12122
CODEINE PHOSPHATE INJECTION USP 30MG LIQUID Discontinued 2022-04-20 2022-04-20 159064
COMTAN 200MG TABLET Discontinued 2022-03-03 2022-03-04 155940
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Discontinued 2018-08-27 2019-01-02 59179
FOLIC ACID INJECTION USP 5MG LIQUID To be discontinued 2019-05-01 2019-05-01 82956
FOLIC ACID INJECTION USP 5MG LIQUID Discontinued 2020-01-28 2020-01-28 104481
HEPARIN SODIUM INJECTION USP (SINGLE USE VIAL-PRESERVATIVE FREE) 10000UNIT SOLUTION Discontinued 2018-07-04 2018-07-31 54349
HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE) 10000UNIT SOLUTION Discontinued 2023-10-18 2023-10-19 207275
IMIPENEM AND CILASTATIN FOR INJECTION USP 250MG 250MG POWDER FOR SOLUTION Discontinued 2021-08-23 2021-08-23 144467
LORAZEPAM INJECTION USP 2MG SOLUTION Discontinued 2020-02-14 2020-03-12 106265
MICRO PLUS 6 (CONCENTRATE) 75MCG 60MCG 10MCG 0.5MG 1MG 5MG LIQUID Discontinued 2021-10-25 2021-10-26 147927
MILRINONE LACTATE INJECTION 1MG SOLUTION Discontinued 2022-06-17 2022-06-18 163000
OLANZAPINE FOR INJECTION 10MG POWDER FOR SOLUTION Discontinued 2020-06-22 2020-06-22 118553
POLYTOPIC 500UNIT 10000UNIT OINTMENT Discontinued 2020-04-01 2020-04-01 110309

Showing 1 to 20 of 74